Half-year report · Q2
3645.TEDINET S100V2YB
Period2024-06-01 → 2024-11-30
Filed2025-01-14
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 44
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥2.9bn | 2024-06-01 → 2024-11-30 | Cons. | Net sales |
| Revenue | ¥5.3bn | 2023-06-01 → 2024-05-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥2.3bn | 2023-06-01 → 2023-11-30 | Cons. | Net sales |
| Operating income | ¥48m | 2024-06-01 → 2024-11-30 | Cons. | Operating income |
| Operating income | ¥170m | 2023-06-01 → 2023-11-30 | Cons. | Operating income |
| Ordinary income | ¥67m | 2024-06-01 → 2024-11-30 | Cons. | Ordinary income |
| Ordinary income | ¥323m | 2023-06-01 → 2024-05-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥194m | 2023-06-01 → 2023-11-30 | Cons. | Ordinary income |
| Profit before tax | ¥59m | 2024-06-01 → 2024-11-30 | Cons. | Income before income taxes |
| Profit before tax | ¥192m | 2023-06-01 → 2023-11-30 | Cons. | Income before income taxes |
| Net income (owners) | −¥17m | 2024-06-01 → 2024-11-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥6m | 2023-06-01 → 2024-05-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥116m | 2023-06-01 → 2023-11-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥1m | 2024-06-01 → 2024-11-30 | Cons. | Profit loss |
| Net income | ¥126m | 2023-06-01 → 2023-11-30 | Cons. | Profit loss |
| Total assets | ¥4.4bn | at 2024-11-30 | Cons. | Assets |
| Total assets | ¥4.0bn | at 2024-05-31 | Cons. | Assets |
| Total assets | ¥3.6bn | at 2023-11-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥2.5bn | at 2024-11-30 | Cons. | Liabilities |
| Total liabilities | ¥2.1bn | at 2024-05-31 | Cons. | Liabilities |
| Net assets / equity | ¥1.9bn | at 2024-11-30 | Cons. | Net assets |
| Net assets / equity | ¥1.9bn | at 2024-05-31 | Cons. | Net assets |
| Net assets / equity | ¥2.0bn | at 2023-11-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥1.4bn | at 2024-11-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥1.5bn | at 2024-05-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥1.4bn | at 2024-11-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.5bn | at 2024-05-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.4bn | at 2023-11-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥1.5bn | at 2023-05-31d | Cons. | Cash and cash equivalents |
| Operating cash flow | −¥56m | 2024-06-01 → 2024-11-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥120m | 2023-06-01 → 2024-05-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | −¥131m | 2023-06-01 → 2023-11-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥23m | 2024-06-01 → 2024-11-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥285m | 2023-06-01 → 2024-05-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥14m | 2023-06-01 → 2023-11-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥21m | 2024-06-01 → 2024-11-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥144m | 2023-06-01 → 2024-05-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥14m | 2023-06-01 → 2023-11-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥-1.89 | 2024-06-01 → 2024-11-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥0.66 | 2023-06-01 → 2024-05-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥12.8 | 2023-06-01 → 2023-11-30 | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 42.5% | at 2024-11-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 47.8% | at 2024-05-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 56.4% | at 2023-11-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 45
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2024-06-01 → 2024-11-30 | ¥908,000 |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2024-06-01 → 2024-11-30 | ¥908,000 |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2024-06-01 → 2024-11-30 | ¥908,000 |
| jpcrp040300-q2r_E24982-000Cloud Integrationreportable segment | revenue | 2024-06-01 → 2024-11-30 | ¥219m |
| jpcrp040300-q2r_E24982-000Cloud Integrationreportable segment | revenue external | 2024-06-01 → 2024-11-30 | ¥219m |
| jpcrp040300-q2r_E24982-000Cloud Integrationreportable segment | segment profit | 2024-06-01 → 2024-11-30 | ¥41m |
| jpcrp040300-q2r_E24982-000Mediaplatformreportable segment | revenue | 2024-06-01 → 2024-11-30 | ¥546m |
| jpcrp040300-q2r_E24982-000Mediaplatformreportable segment | revenue external | 2024-06-01 → 2024-11-30 | ¥546m |
| jpcrp040300-q2r_E24982-000Mediaplatformreportable segment | segment profit | 2024-06-01 → 2024-11-30 | ¥279m |
| jpcrp040300-q2r_E24982-000Medical B To Breportable segment | revenue | 2024-06-01 → 2024-11-30 | ¥87m |
| jpcrp040300-q2r_E24982-000Medical B To Breportable segment | revenue external | 2024-06-01 → 2024-11-30 | ¥87m |
| jpcrp040300-q2r_E24982-000Medical B To Breportable segment | segment profit | 2024-06-01 → 2024-11-30 | −¥11m |
| jpcrp040300-q2r_E24982-000Medical Institution Management Supportreportable segment | revenue | 2024-06-01 → 2024-11-30 | ¥2.0bn |
| jpcrp040300-q2r_E24982-000Medical Institution Management Supportreportable segment | revenue external | 2024-06-01 → 2024-11-30 | ¥2.0bn |
| jpcrp040300-q2r_E24982-000Medical Institution Management Supportreportable segment | segment profit | 2024-06-01 → 2024-11-30 | ¥83m |
| jpcrp040300-q2r_E24982-000Pre Symptomatic And Preventive Disease Platformreportable segment | revenue | 2024-06-01 → 2024-11-30 | ¥19m |
| jpcrp040300-q2r_E24982-000Pre Symptomatic And Preventive Disease Platformreportable segment | revenue external | 2024-06-01 → 2024-11-30 | ¥19m |
| jpcrp040300-q2r_E24982-000Pre Symptomatic And Preventive Disease Platformreportable segment | segment profit | 2024-06-01 → 2024-11-30 | −¥104m |
| —segment total | revenue | 2024-06-01 → 2024-11-30 | ¥2.9bn |
| —segment total | revenue external | 2024-06-01 → 2024-11-30 | ¥2.9bn |
| —segment total | segment profit | 2024-06-01 → 2024-11-30 | ¥287m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2024-06-01 → 2024-11-30 | ¥2.9bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2024-06-01 → 2024-11-30 | ¥2.9bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2024-06-01 → 2024-11-30 | ¥288m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2023-06-01 → 2023-11-30 | ¥2m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2023-06-01 → 2023-11-30 | ¥2m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2023-06-01 → 2023-11-30 | ¥2m |
| jpcrp040300-q2r_E24982-000Mediaplatformreportable segment | revenue | 2023-06-01 → 2023-11-30 | ¥562m |
| jpcrp040300-q2r_E24982-000Mediaplatformreportable segment | revenue external | 2023-06-01 → 2023-11-30 | ¥562m |
| jpcrp040300-q2r_E24982-000Mediaplatformreportable segment | segment profit | 2023-06-01 → 2023-11-30 | ¥315m |
| jpcrp040300-q2r_E24982-000Medical B To Breportable segment | revenue | 2023-06-01 → 2023-11-30 | ¥70m |
| jpcrp040300-q2r_E24982-000Medical B To Breportable segment | revenue external | 2023-06-01 → 2023-11-30 | ¥70m |
| jpcrp040300-q2r_E24982-000Medical B To Breportable segment | revenue intersegment | 2023-06-01 → 2023-11-30 | ¥7,000 |
| jpcrp040300-q2r_E24982-000Medical B To Breportable segment | segment profit | 2023-06-01 → 2023-11-30 | ¥7m |
| jpcrp040300-q2r_E24982-000Medical Institution Management Supportreportable segment | revenue | 2023-06-01 → 2023-11-30 | ¥1.7bn |
| jpcrp040300-q2r_E24982-000Medical Institution Management Supportreportable segment | revenue external | 2023-06-01 → 2023-11-30 | ¥1.7bn |
| jpcrp040300-q2r_E24982-000Medical Institution Management Supportreportable segment | segment profit | 2023-06-01 → 2023-11-30 | ¥68m |
| —segment total | revenue | 2023-06-01 → 2023-11-30 | ¥2.3bn |
| —segment total | revenue external | 2023-06-01 → 2023-11-30 | ¥2.3bn |
| —segment total | revenue intersegment | 2023-06-01 → 2023-11-30 | ¥7,000 |
| —segment total | segment profit | 2023-06-01 → 2023-11-30 | ¥390m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2023-06-01 → 2023-11-30 | ¥2.3bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2023-06-01 → 2023-11-30 | ¥2.3bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2023-06-01 → 2023-11-30 | ¥7,000 |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2023-06-01 → 2023-11-30 | ¥392m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 542
| Item | Context | Value | Unit |
|---|---|---|---|
| Current liabilities | Prior1YearInstant | 1622333000 | JPY |
| Current liabilities | CurrentQuarterInstant | 2058494000 | JPY |
| Long term loans payable | Prior1YearInstant | 387024000 | JPY |
| Long term loans payable | CurrentQuarterInstant | 355346000 | JPY |
| Net defined benefit liability | Prior1YearInstant | 40855000 | JPY |
| Net defined benefit liability | CurrentQuarterInstant | 43558000 | JPY |
| Deferred tax liabilities | Prior1YearInstant | 192000 | JPY |
| Deferred tax liabilities | CurrentQuarterInstant | － | JPY |
| Other ncl | Prior1YearInstant | 7259000 | JPY |
| Other ncl | CurrentQuarterInstant | 6381000 | JPY |
| Noncurrent liabilities | Prior1YearInstant | 435332000 | JPY |
| Noncurrent liabilities | CurrentQuarterInstant | 405285000 | JPY |
| Liabilities | Prior1YearInstant | 2057665000 | JPY |
| Liabilities | CurrentQuarterInstant | 2463780000 | JPY |
| Capital stock | Prior1YearInstant | 286034000 | JPY |
| Capital stock | CurrentQuarterInstant | 286034000 | JPY |
| Capital surplus | Prior1YearInstant | 337314000 | JPY |
| Capital surplus | CurrentQuarterInstant | 337314000 | JPY |
| Retained earnings | Prior1YearInstant | 1693813000 | JPY |
| Retained earnings | CurrentQuarterInstant | 1649638000 | JPY |
| Treasury stock | Prior1YearInstant | -443718000 | JPY |
| Treasury stock | CurrentQuarterInstant | -459364000 | JPY |
| Shareholders equity | Prior1YearInstant | 1873444000 | JPY |
| Shareholders equity | CurrentQuarterInstant | 1813622000 | JPY |
| Valuation difference on available for sale securities | Prior1YearInstant | 4031000 | JPY |
| Valuation difference on available for sale securities | CurrentQuarterInstant | 4031000 | JPY |
| Foreign currency translation adjustment | Prior1YearInstant | 29749000 | JPY |
| Foreign currency translation adjustment | CurrentQuarterInstant | 31289000 | JPY |
| Valuation and translation adjustments | Prior1YearInstant | 33781000 | JPY |
| Valuation and translation adjustments | CurrentQuarterInstant | 35320000 | JPY |
| Non controlling interests | Prior1YearInstant | 24683000 | JPY |
| Non controlling interests | CurrentQuarterInstant | 41643000 | JPY |
| Net assets | Prior1YearInstant | 1931908000 | JPY |
| Net assets | CurrentQuarterInstant | 1890587000 | JPY |
| Liabilities and net assets | Prior1YearInstant | 3989574000 | JPY |
| Liabilities and net assets | CurrentQuarterInstant | 4354368000 | JPY |
| Net sales | Prior1YTDDuration | 2342045000 | JPY |
| Net sales | CurrentYTDDuration | 2912520000 | JPY |
| Cost of sales | Prior1YTDDuration | 1455560000 | JPY |
| Cost of sales | CurrentYTDDuration | 1921830000 | JPY |
| Gross profit | Prior1YTDDuration | 886484000 | JPY |
| Gross profit | CurrentYTDDuration | 990690000 | JPY |
| Selling general and administrative expenses | Prior1YTDDuration | 716696000 | JPY |
| Selling general and administrative expenses | CurrentYTDDuration | 943086000 | JPY |
| Operating income | Prior1YTDDuration | 169788000 | JPY |
| Operating income | CurrentYTDDuration | 47604000 | JPY |
| Interest and dividends income noi | Prior1YTDDuration | 708000 | JPY |
| Interest and dividends income noi | CurrentYTDDuration | 1352000 | JPY |
| Reversal of allowance for doubtful accounts noi | Prior1YTDDuration | － | JPY |
| Reversal of allowance for doubtful accounts noi | CurrentYTDDuration | 474000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |